I like this bit
Commercialisinga pipeline of next generation vaccines
•Immunotherapies with Professor Ian Frazer’s team
•Revenue + significant value drivers over the next 12 –36 months
so they are expecting revenue from this in the next 12-36 months.
seeing as hpv isn't in phase 1 yet and hsv has only completed phase 1, I am guessing their is a deal on the way.
Ann: AGM - Presentation to Shareholders, page-2
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.15 |
Change
-0.350(1.63%) |
Mkt cap ! $406.2M | |||
| Open | High | Low | Value | Volume |
| $21.25 | $21.25 | $21.15 | $53.18K | 2.509K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 493 | $21.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.19 | 100 | 1 |
View Market Depth
| Last trade - 10.28am 07/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |